IVAL is named as a semi-finalist in the "Transform Tox Testing Challenge" created to improve chemical screening. IVAL continues its series of innovative approaches to the comprehensive understanding of toxicity. The Transform Tox Testing Challenge was created by a coalition of Federal Agencies.
Take your research into a new dimension! Introducing Hep-I-Spheres™: 3D in vitro hepatocyte spheroid cultures for ADMET studies. Hep-I-Spheres™species: Human (multiple donors), Rat, Mouse, Dog, Monkey. Next production date: Thursday, October 27th.
In Vitro Admet Laboratories
Research services and products
In Vitro ADMET Laboratories, Inc. (IVAL) offers products and contract services that represent our past three decades of expertise in the application of in vitro experimental systems to evaluate drug absorption, metabolism, drug-drug interactions and drug toxicity.
Based in Columbia, Maryland, IVAL seeks to enhance drug development efficiency through state-of-the-art contract research services. Our dedicated group of professionals have worked and collaborated with various government agencies and for small to big pharma both domestic and international. We aim to expedite the drug development process by providing innovative research techniques to get data to decision-makers fast. By partnering with our clients, we serve as an extension of their research arm to get tomorrow’s solutions here today.
- Primary Cell Cytotoxicity Assay
- Multiple Organ Toxicity Screening
- Organ-specific Toxicity Screening
- Anti-cancer Drug Screening
- Metabolism Dependent Cytotoxicity
- Drug-drug Interaction Assay
- Pathway Determination Assay
- P450 Inhibition Assay
- P450 Induction Assay
- Adverse Drug Effects Assay
- Metabolite Profiling
- Gene Expression Assay
- Contract Research